Find Grants for School Districts
Find out if you qualify for verified grants for School Districts. Discover your eligibility and key funding details for School Districts from major foundations and government agencies.
Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)
Deadline: January 7, 2028
Opportunity Number: PAR-25-206
Agency: National Institutes of Health
Open Date: October 31, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-233
Agency: National Institutes of Health
Open Date: October 30, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.399, 93.242, 93.121, 93.279, 93.310, 93.113, 93.853, 93.172, 93.989, 93.273, 93.865, 93.866
Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required)
Deadline: July 14, 2026
Opportunity Number: PAR-24-313
Agency: National Institutes of Health
Open Date: October 30, 2024
Close Date: July 14, 2026
Status: Posted
CFDA Numbers: 93.213
Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-185
Agency: National Institutes of Health
Open Date: October 30, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.865, 93.121, 93.351
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)
Deadline: July 14, 2026
Opportunity Number: PAR-24-312
Agency: National Institutes of Health
Open Date: October 29, 2024
Close Date: July 14, 2026
Status: Posted
CFDA Numbers: 93.213
Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)
Deadline: April 15, 2027
Opportunity Number: PAR-25-131
Agency: National Institutes of Health
Open Date: October 29, 2024
Close Date: April 15, 2027
Status: Posted
CFDA Numbers: 93.879
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-144
Agency: National Institutes of Health
Open Date: October 29, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.279, 93.242, 93.273, 93.866, 93.847, 93.307, 93.172, 93.846, 93.399, 93.853, 93.837, 93.361, 93.867, 93.855, 93.213, 93.121, 93.865, 93.113, 93.839, 93.840, 93.233, 93.838, 93.310
Translational Neural Devices (R61/R33 - Clinical Trial Optional)
Deadline: January 28, 2027
Opportunity Number: PAR-25-053
Agency: National Institutes of Health
Open Date: October 29, 2024
Close Date: January 28, 2027
Status: Posted
CFDA Numbers: 93.853
Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-024
Agency: National Institutes of Health
Open Date: October 28, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.853, 93.866
Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards (U01 - Clinical Trials Required)
Deadline: November 5, 2027
Opportunity Number: PAR-25-149
Agency: National Institutes of Health
Open Date: October 28, 2024
Close Date: November 5, 2027
Status: Posted
CFDA Numbers: 93.853
Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)
Deadline: November 16, 2027
Opportunity Number: PAR-25-122
Agency: National Institutes of Health
Open Date: October 28, 2024
Close Date: November 16, 2027
Status: Posted
CFDA Numbers: 93.121, 93.853, 93.173, 93.350, 93.855, 93.242
BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional)
Deadline: June 15, 2027
Opportunity Number: RFA-MH-26-140
Agency: National Institutes of Health
Open Date: October 23, 2024
Close Date: June 15, 2027
Status: Posted
CFDA Numbers: 93.286, 93.173, 93.867, 93.213, 93.273, 93.853, 93.866, 93.242, 93.865
NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Deadline: January 6, 2028
Opportunity Number: PAR-25-057
Agency: National Institutes of Health
Open Date: October 23, 2024
Close Date: January 6, 2028
Status: Posted
CFDA Numbers: 93.121
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)
Deadline: October 20, 2027
Opportunity Number: PAR-25-060
Agency: National Institutes of Health
Open Date: October 22, 2024
Close Date: October 20, 2027
Status: Posted
CFDA Numbers: 93.853
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
Deadline: October 20, 2027
Opportunity Number: PAR-25-059
Agency: National Institutes of Health
Open Date: October 22, 2024
Close Date: October 20, 2027
Status: Posted
CFDA Numbers: 93.853
NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)
Deadline: October 15, 2027
Opportunity Number: PAR-25-120
Agency: National Institutes of Health
Open Date: October 18, 2024
Close Date: October 15, 2027
Status: Posted
CFDA Numbers: 93.173
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
Deadline: October 14, 2026
Opportunity Number: PAR-25-074
Agency: National Institutes of Health
Open Date: October 15, 2024
Close Date: October 14, 2026
Status: Posted
CFDA Numbers: 93.394
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
Deadline: October 14, 2026
Opportunity Number: PAR-25-075
Agency: National Institutes of Health
Open Date: October 15, 2024
Close Date: October 14, 2026
Status: Posted
CFDA Numbers: 93.394
Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)
Deadline: July 14, 2026
Opportunity Number: PAR-24-276
Agency: National Institutes of Health
Open Date: October 15, 2024
Close Date: July 14, 2026
Status: Posted
CFDA Numbers: 93.213
Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required)
Deadline: January 6, 2028
Opportunity Number: PAR-25-062
Agency: National Institutes of Health
Open Date: October 10, 2024
Close Date: January 6, 2028
Status: Posted
CFDA Numbers: 93.121
Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
Deadline: January 7, 2027
Opportunity Number: PAR-25-098
Agency: National Institutes of Health
Open Date: October 10, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.399, 93.307, 93.121, 93.313
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
Deadline: October 14, 2026
Opportunity Number: PAR-24-304
Agency: National Institutes of Health
Open Date: October 10, 2024
Close Date: October 14, 2026
Status: Posted
CFDA Numbers: 93.394
Occupational Safety and Health Education and Research Centers (T42)
Deadline: October 26, 2028
Opportunity Number: RFA-OH-25-002
Agency: Centers for Disease Control and Prevention - ERA
Open Date: October 7, 2024
Close Date: October 26, 2028
Status: Posted
CFDA Numbers: 93.262
Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PA-25-093
Agency: National Institutes of Health
Open Date: October 4, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.855, 93.846
Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional)
Deadline: June 22, 2026
Opportunity Number: PAR-25-050
Agency: National Institutes of Health
Open Date: October 2, 2024
Close Date: June 22, 2026
Status: Posted
CFDA Numbers: 93.853
